Bundamedik Tbk vs Sinergi Inti Andalan Prima Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Sinergi Inti Andalan Prima Tbk. trades at Rp214 (market cap 4.88T, 267.29M 24h volume). The key difference: Sinergi Inti Andalan Prima Tbk. is far larger — about 3.2× Bundamedik Tbk's market cap, and Sinergi Inti Andalan Prima Tbk. is more actively traded (267.29M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | INET | |
|---|---|---|
Market Cap | 1.51T | 4.88T |
Volume | 536.7K | 267.29M |
Lot | 5.37K | 2.67M |
Turnover | 93.41M | 58.7B |
Average Price | 174.05 | 219.62 |
Value | 93.41M | 58.7B |
Indicative Equilibrium Price | 176 | 214 |
Indicative Equilibrium Volume | 100 | 38.07K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Read more on INET →